Adapalene USP Related Compound A: Chemical Structure, Characterization, and Analytical Significance

Adapalene is a third-generation synthetic retinoid widely used in dermatological formulations, particularly for the management of acne vulgaris. Its chemical structure and selective interaction with retinoic acid receptors distinguish it from several older retinoid compounds. As with other pharmaceutical substances, maintaining the quality, identity, and purity of Adapalene requires appropriate analytical evaluation throughout its manufacturing and quality control processes.

An important part of this evaluation involves understanding related compounds and potential impurities associated with pharmaceutical synthesis. Adapalene USP Related Compound A is a specific reference compound relevant to the analytical assessment of Adapalene. Its identification and characterization support impurity profiling, reference-standard comparison, and pharmaceutical quality investigations.

Understanding its chemical structure, physicochemical characteristics, and analytical significance helps pharmaceutical scientists, analytical researchers, and quality control professionals develop a more comprehensive approach to impurity evaluation.

Understanding Adapalene USP Related Compound A

Adapalene USP Related Compound A is identified chemically as Methyl 6-bromo-2-naphthoate. It is an aromatic brominated ester compound associated with the structural chemistry relevant to Adapalene-related pharmaceutical analysis.

Adapalene contains a substituted naphthoic acid framework, making the structural characteristics of related aromatic intermediates important when investigating its synthesis and impurity profile.

Related compounds are important in pharmaceutical analysis because they provide defined chemical identities against which samples can be evaluated. Rather than relying exclusively on general purity measurements, analysts can use suitable reference standards to investigate the presence of specific compounds.

For pharmaceutical manufacturers and analytical laboratories, Adapalene USP Related Compound A can therefore serve as a useful reference material in appropriate identification and impurity assessment procedures.

Chemical Structure and Physicochemical Characteristics

The chemical identity of Adapalene USP Related Compound A provides the foundation for understanding its analytical behaviour.

Chemical information:

Chemical Name: Methyl 6-bromo-2-naphthoate

CAS Number: 33626-98-1

Molecular Formula: C₁₂H₉BrO₂

Molecular Weight: 265.10 g/mol

Chemical Class: Brominated aromatic ester

Compound Category: Adapalene USP Related Compound A

Its molecular structure consists of a fused bicyclic naphthalene ring system containing a bromine substituent and a methyl ester functional group.

The aromatic ring system contributes to the compound's characteristic structural framework, while the bromine atom and ester functionality provide additional chemical features that are relevant to its identification and characterization.

These structural elements are useful when selecting analytical techniques and interpreting the resulting data. In particular, molecular mass, functional-group characteristics, and chromatographic behaviour can help distinguish the compound from other structurally related substances.

Characterization of Adapalene USP Related Compound A

Characterization is essential for establishing the identity and assessing the quality of pharmaceutical reference materials. For Adapalene USP Related Compound A, different analytical techniques can provide complementary information about its molecular structure and chemical properties.

1. High-Performance Liquid Chromatography (HPLC)

HPLC is commonly used in pharmaceutical laboratories for evaluating chromatographic purity and separating related substances. It can help assess the presence of the target compound alongside other components in a sample.

When an appropriate analytical method is established, comparison with a qualified reference standard can support peak identification and impurity evaluation.

2. Liquid Chromatography–Mass Spectrometry (LC-MS)

LC-MS combines chromatographic separation with mass-based detection. It is useful for investigating molecular characteristics and supporting the identification of compounds in complex analytical samples.

The brominated molecular structure of Adapalene USP Related Compound A provides a useful feature for mass-spectrometric investigation. However, ionization efficiency and observed signals depend on the instrument configuration and analytical conditions.

3. Nuclear Magnetic Resonance (NMR) Spectroscopy

NMR spectroscopy provides information about the molecular environment of hydrogen and carbon atoms. Proton NMR and carbon NMR can help examine the aromatic framework, methyl ester group, and overall structural consistency.

It is particularly valuable when confirming the identity of synthesized reference materials or investigating structural differences between related compounds.

4. Infrared (IR) Spectroscopy

IR spectroscopy helps identify characteristic functional groups through their vibrational absorption patterns. The ester carbonyl and other structural features can contribute to the compound's infrared spectrum.

IR analysis can therefore provide complementary evidence during structural characterization.

The selection and interpretation of these techniques should depend on the analytical objective, validated procedures, and applicable reference-standard requirements.

Analytical Significance in Pharmaceutical Quality Control

Pharmaceutical quality control requires more than confirming the identity of an active pharmaceutical ingredient (API). It also involves evaluating related substances that may originate from manufacturing processes, raw materials, intermediates, or degradation pathways.

The United States Pharmacopeia (USP) recognizes Adapalene Related Compound A as a specific reference standard in its Adapalene monograph. This establishes its relevance to the official analytical framework for Adapalene quality evaluation.

Its analytical significance can be understood through several applications:

Impurity identification: Supports the investigation of a specific related compound in Adapalene samples.

Chromatographic evaluation: Helps analysts establish and interpret the identity of relevant chromatographic peaks.

Reference-standard comparison: Provides a defined chemical material for comparison during appropriate analytical procedures.

Method development: Can support the development and assessment of analytical methods designed to evaluate related substances.

Quality investigations: Helps pharmaceutical laboratories investigate unexpected chromatographic findings and potential process-related impurities.

The USP monograph also describes different organic-impurity procedures depending on which related compounds may be present based on the manufacturing route. This highlights why understanding individual related compounds is important in pharmaceutical analysis.

Importance of Pharmaceutical Impurity Reference Standards

Pharmaceutical impurity reference standards are essential tools for laboratories involved in analytical development, manufacturing, and quality assurance.

A well-characterized reference standard helps establish a reliable basis for comparing analytical results. It can also support the evaluation of chromatographic separation, peak identification, and method performance.

For compounds such as Adapalene USP Related Compound A, laboratories benefit from access to reference materials with clearly documented chemical identity and supporting analytical information.

Reference standards are particularly useful in:

• Pharmaceutical research and development.

• Analytical method development and verification.

• Related-substance testing.

• Impurity profiling.

• Stability-indicating analytical investigations.

• Pharmaceutical quality control and documentation.

It is important to distinguish between a reference standard used for analytical research and a pharmaceutical ingredient intended for human use. These materials serve different purposes and must be handled according to their applicable documentation and intended applications.

Chemicea Pharmaceuticals: Adapalene USP Related Compound A Reference Standard

Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical reference standards manufacturer and supplier specializing in impurity standards, custom synthesis, and analytical solutions.

The company supports pharmaceutical manufacturers, research organizations, analytical laboratories, and quality control professionals by offering reference materials for pharmaceutical impurity identification and characterization.

For Adapalene USP Related Compound A, Chemicea offers the compound under the following product details:

Product Name: Adapalene USP Related Compound A

Chemical Name: Methyl 6-bromo-2-naphthoate

CAS Number: 33626-98-1

CAT Number: CP-A48005

Molecular Formula: C₁₂H₉BrO₂

Molecular Weight: 265.10 g/mol

The product listing includes supporting documentation such as a Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS). The published product information also identifies the compound as an impurity standard of Adapalene.

Beyond this specific compound, Chemicea provides a broader range of Adapalene-related pharmaceutical reference standards, including process impurities, degradation impurities, and other related compounds. The company also offers custom synthesis capabilities to support specialized research and analytical requirements.

Conclusion

Adapalene USP Related Compound A, chemically identified as Methyl 6-bromo-2-naphthoate, is an important compound within the USP framework for Adapalene-related impurity evaluation. Its defined molecular structure and chemical characteristics make it relevant to analytical identification, chromatographic investigation, and pharmaceutical quality control.

Techniques such as HPLC, LC-MS, NMR, and IR spectroscopy can provide complementary information for its characterization and evaluation. Access to suitable reference standards further supports pharmaceutical laboratories in developing reliable analytical procedures and investigating related substances.

With its portfolio of pharmaceutical impurity reference standards, custom synthesis capabilities, and analytical support, Chemicea Pharmaceuticals contributes to the research and quality evaluation requirements of the pharmaceutical industry.